Heterocyclylaminoalkyl substituted benzimidazoles

Details for Australian Patent Application No. 2006260970 (hide)

Owner Tibotec Pharmaceuticals Ltd

Inventors Fortin, Jerome Michel Claude; Doublet, Frederic Marc Maurice; Muller, Philippe; Bonfanti, Jean-Francois

Agent Shelston IP

Pub. Number AU-B-2006260970

PCT Pub. Number WO2006/136562

Priority 05076439.8 20.06.05 EP

Filing date 20 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 5 July 2012

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 31/4184

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136562 Priority application(s): WO2006/136562

7 February 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Tibotec Pharmaceuticals Ltd., Application No. 2006260970, under INID (71), correct the applicant name to Tibotec Pharmaceuticals Ltd

5 July 2012 Application Accepted

  Published as AU-B-2006260970

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260971-2-substituted benzimidazoles

2006260969-1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) - 3-substituted-1,3-dihydro-benzoimidazo l-2-ones with activity on respiratory syncytial virus